Los Angeles, CA -- (SBWire) -- 02/16/2019 --The global Rosuvastatin Calcium market report offers a complete research study that includes accurate estimations of market growth rate and size for the forecast period 2019-2025. It offers a broad analysis of market competition, regional expansion, and market segmentation by type, application, and geography supported by exact market figures. The all-inclusive market research report also offers Porter's Five Forces Analysis and profiles some of the leading players of the global Rosuvastatin Calcium market. It sheds light on changing market dynamics and discusses about different growth drivers, market challenges and restraints, and trends and opportunities in detail. Interested parties are provided with market recommendations and business advice to ensure success in the global Rosuvastatin Calcium market.
The global Rosuvastatin Calcium market is valued at 430 million US$ in 2018 is expected to reach 590 million US$ by the end of 2025, growing at a CAGR of 4.0% during 2019-2025.
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
With the raw material advantage, EU is the dominate producer and exporter in rosuvastatin calcium industry. The production market share of EU has reached about 35.25% in 2015. In additional, EU is also the largest consumer of rosuvastatin calcium, about 34.47% of the global production was consumed in EU in 2015. China is the second producer with the market share of 28.82% in 2015. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55.09% of the total amount in 2015.
This report focuses on Rosuvastatin Calcium volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rosuvastatin Calcium market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
Get PDF report template: https://www.qyresearch.com/sample-form/form/965147/global-rosuvastatin-calcium-industry-depth-survey-report
Major Companies:
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Others
Segmental Analysis
Market analysts authoring this research study have deeply segmented in the global Rosuvastatin Calcium market and shared an intelligent understanding of the market growth of different segments. The market intelligence provided in the segmental analysis section of the report helps players to decide on the segments that can be trusted for making more investments in.
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Purity 98.0%
Purity 99.0%
Other
Segment by Application
Tablet (including dispersible tablet and general tablet)
Capsule
Others
For on-demand customization of the report, visit:
Our market researchers follow industry-best primary and secondary research methodologies to compile highly comprehensive and meticulous reports. We conduct personal interviews with industry experts, market leaders, and other important entities to gather data for our reports. We also refer to company websites, government documents, quarterly and full year financial reports, press releases, and recent updates from authorized organizations for collecting information related to the concerned market. Before publishing our reports, we perform validation as well as revalidation of the data and information included.
Access Full Comprehensive Industry Insights (Report USD 2900):https://www.qyresearch.com/settlement/pre/005c534e4092709a3e0c7c0e03bac52f,0,1,Global%20Rosuvastatin%20Calcium%20Industry%20Depth%20Survey%20Report%202019
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Rosuvastatin Calcium Market Will Surge at 4.0% CAGR to Reach 590 Million US$ by the End of 2025
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.